You are here

  • Home
  • Archive
  • Volume 76, Issue 1
  • A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy

Citation Tools

Article menu
Clinical and epidemiological research
Extended report
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Emery P, Vencovský J, Sylwestrzak A, et al
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
Annals of the Rheumatic Diseases 2017;76:51-57.